384 related articles for article (PubMed ID: 31681747)
1. Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma.
Meng T; Huang R; Zeng Z; Huang Z; Yin H; Jiao C; Yan P; Hu P; Zhu X; Li Z; Song D; Zhang J; Cheng L
Front Bioeng Biotechnol; 2019; 7():270. PubMed ID: 31681747
[No Abstract] [Full Text] [Related]
2. Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma.
Huang R; Yan G; Sun H; Zhang J; Song D; Kong R; Yan P; Hu P; Xie A; Wang S; Zhuang J; Yin H; Meng T; Huang Z
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32627826
[TBL] [Abstract][Full Text] [Related]
3. Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme.
Huang R; Li Z; Li C; Wang G; Yan P; Peng L; Wang J; Zhu X; Hu P; Zhang J; Chang Z; Huang Z; Cheng L; Zhang J
Front Genet; 2019; 10():1380. PubMed ID: 32117422
[TBL] [Abstract][Full Text] [Related]
4. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
5. The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma.
Huang R; Li M; Zeng Z; Zhang J; Song D; Hu P; Yan P; Xian S; Zhu X; Chang Z; Zhang J; Guo J; Yin H; Meng T; Huang Z
Cancer Control; 2022; 29():10732748211051554. PubMed ID: 34986671
[TBL] [Abstract][Full Text] [Related]
6. The Construction of Bone Metastasis-Specific Prognostic Model and Co-expressed Network of Alternative Splicing in Breast Cancer.
Huang R; Guo J; Yan P; Zhai S; Hu P; Zhu X; Zhang J; Qiao Y; Zhang Y; Liu H; Huang L; Zhang J; Yang D; Huang Z
Front Cell Dev Biol; 2020; 8():790. PubMed ID: 32984314
[TBL] [Abstract][Full Text] [Related]
7. Identification of prognostic and bone metastasis​-related alternative splicing signatures in mesothelioma.
Huang R; Zheng Z; Liu S; Yan P; Song D; Yin H; Hu P; Zhu X; Chang Z; Liu Y; Zhuang J; Meng T; Huang Z; Zhang J
Cancer Med; 2021 Jul; 10(13):4478-4492. PubMed ID: 34041868
[TBL] [Abstract][Full Text] [Related]
8. Ral GEF with the PH Domain and SH3 Binding Motif 1 Regulated by Splicing Factor Junction Plakoglobin and Pyrimidine Metabolism Are Prognostic in Uterine Carcinosarcoma.
Guo H; Wang S; Xie A; Sun W; Wei C; Xian S; Yin H; Li M; Sun H; Li H; Meng T; Zhang J; Huang Z
Dis Markers; 2021; 2021():1484227. PubMed ID: 34745385
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma.
Xiao L; Zou G; Cheng R; Wang P; Ma K; Cao H; Zhou W; Jin X; Xu Z; Huang Y; Lin X; Nie H; Jiang Q
BMC Cancer; 2021 Jun; 21(1):703. PubMed ID: 34130646
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma.
Chen T; Zheng W; Chen J; Lin S; Zou Z; Li X; Tan Z
J Cell Biochem; 2020 Oct; 121(10):4074-4084. PubMed ID: 31886566
[TBL] [Abstract][Full Text] [Related]
11. miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinoma.
Yu L; Xiang L; Feng J; Li B; Zhou Z; Li J; Lin Y; Lv Y; Zou D; Lei Z; Zhang J
J Cancer; 2018; 9(20):3651-3659. PubMed ID: 30405833
[No Abstract] [Full Text] [Related]
12. Systematic Identification of Survival-Associated Alternative Splicing Events in Kidney Renal Clear Cell Carcinoma.
Wei Y; Zhang Z; Peng R; Sun Y; Zhang L; Liu H
Comput Math Methods Med; 2021; 2021():5576933. PubMed ID: 33959190
[TBL] [Abstract][Full Text] [Related]
13. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide Analysis of the Alternative Splicing Profiles Revealed Novel Prognostic Index for Kidney Renal Cell Clear Cell Carcinoma.
Gao L; He RQ; Huang ZG; Dang YW; Gu YY; Yan HB; Li SH; Chen G
J Cancer; 2020; 11(6):1542-1554. PubMed ID: 32047561
[TBL] [Abstract][Full Text] [Related]
15. Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumors.
Duan C; Zhang Y; Li L; Liu K; Yao X; Wu X; Li B; Mao X; Wu H; Liu H; Zeng J; Li S; Gong Y; Hu Z; Xu H
Front Oncol; 2023; 13():1249932. PubMed ID: 37810965
[TBL] [Abstract][Full Text] [Related]
16. Alternative splicing events are prognostic in hepatocellular carcinoma.
Chen QF; Li W; Wu P; Shen L; Huang ZL
Aging (Albany NY); 2019 Jul; 11(13):4720-4735. PubMed ID: 31301224
[TBL] [Abstract][Full Text] [Related]
17. Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.
Cai Q; He B; Zhang P; Zhao Z; Peng X; Zhang Y; Xie H; Wang X
J Transl Med; 2020 Dec; 18(1):463. PubMed ID: 33287830
[TBL] [Abstract][Full Text] [Related]
18. The Construction and Analysis of ceRNA Network and Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Deng L; Wang P; Qu Z; Liu N
Front Genet; 2021; 12():667610. PubMed ID: 34567057
[No Abstract] [Full Text] [Related]
19. Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.
Zhang P; Li J; Wang Z; Zhao L; Qiu J; Xu Y; Wu G; Xia Q
Front Oncol; 2023; 13():1077309. PubMed ID: 36969076
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data.
Ye P; Yang Y; Zhang L; Zheng G
Front Oncol; 2021; 11():658262. PubMed ID: 34676158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]